About Imricor medical systems
Imricor Medical Systems: Revolutionizing the Catheter Ablation Market
Imricor Medical Systems is a pioneering medical technology company that has revolutionized the catheter ablation market with its innovative iCMR products. The company is the first and only one in the world to bring commercially viable and safe iCMR products to this market, which has been a game-changer for patients suffering from cardiac arrhythmias.
Cardiac arrhythmias are abnormal heart rhythms that can cause serious health problems, including stroke, heart failure, and sudden cardiac arrest. Catheter ablation is a minimally invasive procedure that uses radiofrequency energy or cryotherapy to destroy small areas of heart tissue responsible for causing these abnormal rhythms. However, traditional catheter ablation procedures have limitations due to their reliance on fluoroscopy (X-ray imaging) for guidance.
This is where Imricor's iCMR technology comes in. iCMR stands for "interventional cardiovascular magnetic resonance," which refers to using real-time MRI (magnetic resonance imaging) during catheter ablation procedures instead of X-ray imaging. MRI provides superior soft-tissue visualization without ionizing radiation exposure, making it safer and more accurate than fluoroscopy.
Imricor's flagship product is the Advantage-MRI system, which consists of an MRI-compatible catheter and a dedicated software platform that integrates with existing MRI scanners. The Advantage-MRI system enables real-time visualization of the catheter tip inside the heart during ablation procedures, allowing physicians to precisely target and treat arrhythmia-causing tissue while avoiding healthy tissue.
The Advantage-MRI system has several advantages over traditional fluoroscopy-guided systems:
1. Improved safety: By eliminating ionizing radiation exposure from X-rays, patients and healthcare workers are protected from potential harm.
2. Better accuracy: Real-time MRI provides high-resolution images that allow physicians to see detailed anatomy and track changes in real-time.
3. Reduced procedure time: With better accuracy comes faster procedures since physicians can complete treatments more efficiently.
4. Lower costs: While initial setup costs may be higher than traditional systems due to requiring an MRI scanner as well as Imricor's software platform; however long-term cost savings come from reduced complications rates associated with radiation exposure.
The Advantage-MRI system has received regulatory approval in several countries worldwide including Europe (CE Mark), Canada (Health Canada), Australia/New Zealand (TGA), Japan (PMDA), South Korea (KFDA). In addition it also received FDA clearance in 2020 making it available throughout United States hospitals.
Imricor Medical Systems was founded by Steve Wedan who serves as CEO today along with other industry veterans who have extensive experience developing medical devices specifically designed for use within an MR environment such as Drs Robert Lederman & Henry Halperin both renowned experts within interventional cardiology field .
In conclusion Imricor Medical Systems' innovative iCMR technology represents a significant advancement in cardiac care by providing safer more accurate treatment options for patients suffering from cardiac arrhythmias while also reducing healthcare worker exposure risks associated with traditional X-ray guided systems . With regulatory approvals already granted across multiple countries worldwide , we expect continued growth opportunities ahead as more hospitals adopt this cutting-edge technology into their clinical practice .